Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

Androgenetic alopecia is common hair loss caused by genetics and hormones.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Androgenetic alopecia is a common form of hair loss in both men and women.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Androgenetic alopecia is a common form of hair loss in both men and women.

Androgenic alopecia is hereditary hair loss treated with medications, therapies, and support.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Hair thinning on top of the head is common in female androgenetic alopecia.

Androgenetic Alopecia is commonly known as male or female pattern baldness.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

Androgenetic alopecia causes hair loss, affects men more severely, and treatments are only temporarily effective.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

Androgenetic alopecia is the most common cause of hair loss, affecting both men and women, with varying patterns and prevalence among different races.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hair loss common in men and women, limited treatments available.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

The exact causes of baldness are not fully understood, limiting treatment options.

Atypical male hair loss may not respond to usual treatments.

Androgenic alopecia is male or female pattern baldness.

Androgenetic alopecia causes hair loss, impacting self-esteem and confidence.